Search

everythinglearnresearchcommunity

for

Search:↓

Steroids can treat skin conditions but must be used carefully to avoid side effects.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Scalp sarcoidosis can cause hair loss and needs accurate diagnosis and treatment with specific medications.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Tacrolimus treatment for autoimmune hepatitis can cause hair loss.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Alopecia areata treatments should be personalized, using options like steroids, JAK inhibitors, and other therapies based on individual needs.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Trichoscopy can reveal specific hair and scalp changes in linear morphea.

Systemic lupus erythematosus is managed with lifestyle changes, symptomatic treatments, and careful use of medications to control symptoms and flares.

Stopping Cyclosporine A led to hair regrowth in a child with alopecia.

Timely diagnosis and aggressive treatment with high-dose steroids and B-cell depletion therapies are effective for severe acute cutaneous lupus.

New cytokine-targeted therapies show promise for treating alopecia areata.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

The document concludes that transplantology has evolved with improved techniques and materials, making transplants more successful and expanding the types of transplants possible.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Switching immunosuppressants can improve hair regrowth and well-being in transplant patients experiencing hair loss.

Switching immunosuppressive drugs can improve hair regrowth and well-being in transplant patients with hair loss.

Hair loss from immunosuppressive drugs in transplant patients can affect well-being and treatment adherence, so personalized management is important.

Scalp psoriasis is a chronic condition that can be managed with treatments like corticosteroids and salicylic acid.

Tacrolimus ointment is effective for various skin conditions but needs more research for long-term effects.

Homeopathy might help manage autoimmune diseases.

Pharmacists are key in choosing and guiding the safe use of topical corticosteroids for skin conditions.

Discoid lupus erythematosus can be mistaken for a skin infection, complicating diagnosis and treatment.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.